Percepta: Qualitative use of predictions when designing soft‑drug candidates

Description
Soft drugs are designed to be active locally but rapidly inactivated systemically (e.g., via metabolism). Percepta’s predictions for metabolic stability, clearance, and lipophilicity can support early soft‑drug concept evaluation.

Solution

1. For parent and proposed soft‑drug analogs, obtain Percepta predictions for:
   • Metabolic stability / clearance.
   • logP/logD.
   • Key pKa values (if applicable).
2. For soft‑drug candidates:
   • Look for higher predicted clearance or lower metabolic stability compared with the parent (to favor rapid inactivation).
3. Simultaneously ensure:
   • Local potency or exposure assumptions are still plausible (e.g., via permeability/logD).
   • No major new toxicity alerts are introduced.
4. Rank candidates qualitatively:
   • More suitable soft‑drug profiles vs those likely to be too stable or too unstable.
5. Use these predictions to prioritize which designs to synthesize and test in appropriate local vs systemic models.
6. Treat Percepta outputs as directional: confirm soft‑drug behavior through targeted in vitro and in vivo studies.